FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

781125008: Fremanezumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3744983010 Fremanezumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3744984016 Fremanezumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fremanezumab Has disposition Calcitonin gene-related peptide receptor antagonist true Inferred relationship Existential restriction modifier
Fremanezumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Fremanezumab Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing fremanezumab (medicinal product) Has active ingredient True Fremanezumab Inferred relationship Existential restriction modifier 1
Fremanezumab Has active ingredient True Fremanezumab Inferred relationship Existential restriction modifier 1
Product containing only fremanezumab in parenteral dose form (medicinal product form) Has active ingredient True Fremanezumab Inferred relationship Existential restriction modifier 1
Product containing fremanezumab in parenteral dose form (medicinal product form) Has active ingredient True Fremanezumab Inferred relationship Existential restriction modifier 1
Product containing precisely fremanezumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Fremanezumab Inferred relationship Existential restriction modifier 1
Product containing precisely fremanezumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Fremanezumab Inferred relationship Existential restriction modifier 1
Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices 3 pre-filled disposable injection Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Ajovy 225mg/1.5ml solution for injection pre-filled pens (Teva UK Ltd) 3 pre-filled disposable injection Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Ajovy 225mg/1.5ml solution for injection pre-filled pens (Teva UK Ltd) Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Ajovy 225mg/1.5ml solution for injection pre-filled pens (Teva UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Ajovy 225mg/1.5ml solution for injection pre-filled syringes (Teva UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Ajovy 225mg/1.5ml solution for injection pre-filled syringes (Teva UK Ltd) Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Fremanezumab 225mg/1.5ml solution for injection pre-filled syringes Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier
Fremanezumab 225mg/1.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Fremanezumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start